Home | Welcome to Contract Pharma   
Last Updated Friday, March 6 2015

Print

Breaking News

Related Searches: Manufacturing CMC Phase I Preclinical
Gil Roth
April 19, 2012
Billion-dollar site to support plasma-based treatments  Read More »
Gil Roth
April 19, 2012
Will investigate PDE4 inhibitor in Ib trial  Read More »
Gil Roth
April 19, 2012
HGS rejects $2.6 billion offer from Benlysta partner  Read More »
Gil Roth
April 19, 2012
Advate, Gammagard Liquid drive BioScience growth  Read More »
April 18, 2012
Veteran team to help address CMC questions  Read More »
April 18, 2012
O'Brien brings quality, computer systems and regulatory background to imaging CRO  Read More »
April 18, 2012
FSP alliance outsources highly specialized tasks across drug development pipeline  Read More »
April 18, 2012
1Q Revenues: $9.4 billion (+4%) 1Q Earnings: $1.2 billion (+44%) Comments: Proprietary pharma revenues were up 7% to $4.1 billion, driven by Humira (+17% to $1.9 billion). The established pharma revenues (ex-U.S.) was down 2% to $1.3 billion.…  Read More »
April 17, 2012
Could lead to commercial manufacturing of neuraminidase inhibitor  Read More »
April 17, 2012
Mooney to provide global clinical development leadership  Read More »
April 17, 2012
Adds new technology to boost rate, scale of liquid fill  Read More »
April 17, 2012
Will use GPEx technology to express brain cancer treatment  Read More »
April 17, 2012
1Q Revenues: $16.1 billion (flat) 1Q Earnings: $3.9 billion (+12%) Comments: Pharma sales were $6.3 billion, up 1%, with a slight negative impact from currency rates. Consumer sales dropped 2% to $3.6 billion, as the company continues to struggle w…  Read More »
Gil Roth
April 16, 2012
Detreille named senior director  Read More »
April 16, 2012
Deal uses NMR technology to enhance lead discovery, hit identification  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On